SWOT Analysis for Korro Bio Inc.

Price crossing above SMA20 today, and greater than SMA5
Significant (over 30%) distance from 52 week high
Annual Profit Growth higher than Sector Profit Growth
Top Gainers
Stock with Low PE (PE < = 10)
Biggest Price Gainers from Open

Stocks with Quarter Change % less than Industry
Companies that Declared Results in Past One Week, Showing Declining Net Profit YoY OR QoQ (subscription)
PEG greater than Industry PEG
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Highest fall from 52 Week High
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Annual net profit declining for last 2 years
Weak Momentum: Price below Short, Medium and Long Term Averages
RSI indicating price weakness
Stocks Underperforming their Industry Price Change in the Quarter

Mutual Funds Increased Shareholding in Past Month
Institutions increasing their shareholding
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Mf buying for 2 months

Korro Bio Inc. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats